Performance vs S&P 500

03
Tracked Q2 2025–Q4 2025 +102.7%
S&P 500 total return (same window) +11.9%
Excess return +90.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 99.6% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 88.6%
Other/Unmapped 11.4%

Full portfolio 2 positions

05
Type Streak 8Q trend
ASBP Aspire Biopharma Holdings, Inc. - Common Stock $26,762 88.65% 202,897 $-15,035
ASBPW Aspire Biopharma Holdings, Inc. - Warrant $3,427 11.35% 207,693 $-2,783

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
ASBP Price move only +0 -$15K
ASBPW Price move only +0 -$3K

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
CURR Dec. 31, 2025 263,200 $442,176 70.4%
RZLV Sept. 30, 2025 131,250 $403,594 -55.1%
CHPT (filed as CHPTXXXX) June 30, 2025 50,000 $30,250 -35.7%
THCH June 30, 2025 4,800 $14,064 -59.5%
XAGE June 30, 2025 100,000 $12,500 No longer tracked
PITAW June 30, 2025 1,237,500 $12,499 No longer tracked
LDTDF June 30, 2025 190,500 $11,544 No longer tracked
ECXWW June 30, 2025 165,330 $9,920
XAGEW June 30, 2025 371,250 $8,167 No longer tracked
COCHW June 30, 2025 200,000 $6,600
NUAIW June 30, 2025 37,500 $5,246
NVNIW June 30, 2025 123,400 $3,529
BSLKW June 30, 2025 60,000 $1,800 No longer tracked
MSPRZ June 30, 2025 85,500 $1,719 No longer tracked
CCGWW June 30, 2025 41,000 $1,230 -40.0%